共 182 条
[1]
Alexander TB(2017)Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials Cancer 123 3791-3798
[2]
Wang L(2017)Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia Blood 129 1913-1918
[3]
Inaba H(2018)Have haploidentical transplants replaced umbilical cord transplants for acute leukemias? Curr Opin Hematol 25 103-111
[4]
Triplett BM(2017)T-cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation Biomedicines 123 967-973
[5]
Pounds S(2014)"Designed" grafts for HLA-haploidentical stem cell transplantation Blood 144 818-831
[6]
Ribeiro RC(2009)Rediscovering alemtuzumab: current and emerging therapeutic roles Br J Haematol 96 2419-2425
[7]
Pui CH(2000)In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Blood 49 55-61
[8]
Rubnitz JE(2014)The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT Bone Marrow Transplant 64 278-291
[9]
Campana D(2007)Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response Br J Clin Pharmacol 58 1609-1620
[10]
Pui C-H(2019)Population pharmacokinetics of alemtuzumab (campath) in pediatric hematopoietic cell transplantation: towards individualized dosing to improve outcome Clin Pharmacokinet 10 2769-504